Aurobindo Pharma Limited has informed the Exchange regarding a press release dated November 29, 2023, titled "Aurobindo Pharma receives USFDA Approval for Darunavir Tablets, 600 mg and 800 mg.".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated November 29, 2023, titled "Aurobindo Pharma receives USFDA Approval for Darunavir Tablets, 600 mg and 800 mg.".